Gallwitz, B. (2014). The Future of Combination Therapies of Insulin with a Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes – Is it Advantageous? Eur Endocrinol.
Styl ChicagoGallwitz, Baptist. "The Future of Combination Therapies of Insulin With a Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes – Is It Advantageous?" Eur Endocrinol 2014.
Citace podle MLAGallwitz, Baptist. "The Future of Combination Therapies of Insulin With a Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes – Is It Advantageous?" Eur Endocrinol 2014.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..